Immuno-oncology-based doublet combinations have a highly significant effect on patients with an intermediate or poor prognosis [ 12 ].
← all excerpts
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma.
1
—
—